...
首页> 外文期刊>Pharmacology, Biochemistry and Behavior >Assessment of monoamine transporter inhibition in the mediation of cocaine-induced conditioned taste aversion.
【24h】

Assessment of monoamine transporter inhibition in the mediation of cocaine-induced conditioned taste aversion.

机译:评估可卡因诱导的条件性味觉厌恶介导中单胺转运蛋白抑制作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Although the mechanisms of cocaine reward have been well characterized, the pharmacological basis of cocaine's aversive effects is less understood. Using the conditioned taste aversion (CTA) preparation, the present study examined the role of monoamine uptake inhibition in cocaine's aversive effects by comparing cocaine to three reuptake inhibitors with relative specificity for the transporters of dopamine (DAT; GBR 12909), norepinephrine (NET; desipramine) and serotonin (SERT; clomipramine). Specifically, 104 male Sprague-Dawley rats were given 20-min access to a novel saccharin solution followed immediately by a subcutaneous injection of cocaine, GBR 12909, desipramine, clomipramine (each at 18, 32 or 50 mg/kg; 12 groups) or drug vehicle (equivolume to the highest cocaine dose). Over trials, cocaine and desipramine each dose-dependently suppressed saccharin consumption and did so in an equivalent manner when matched by dose. However, both GBR 12909 and clomipramine conditioned weaker aversions than cocaine at the two lowest doses (18 and 32 mg/kg). At the highest dose (50 mg/kg), GBR 12909 produced equivalent suppression of saccharin consumption to cocaine while clomipramine's conditioned suppression remained relatively weak at this dose. These results suggest that cocaine's adrenergic actions resulting from NET inhibition may play a more significant role in the mediation of its aversive effects than its actions at DAT and SERT.
机译:尽管可卡因奖赏的机制已被很好地表征,但可卡因的厌恶作用的药理基础尚不甚了解。本研究使用条件性味觉厌恶(CTA)制剂,通过比较可卡因与三种对多巴胺转运蛋白(DAT; GBR 12909),去甲肾上腺素(NET;地昔帕明)和5-羟色胺(SERT;氯米帕明)。具体来说,对104只雄性Sprague-Dawley大鼠给予20分钟的新型糖精溶液,然后立即皮下注射可卡因,GBR 12909,地昔帕明,氯米帕明(每组18、32或50 mg / kg; 12组)或毒品媒介(可卡因剂量最高)。在试验中,可卡因和地昔帕明各自剂量依赖性地抑制糖精的消耗,并且当与剂量匹配时以等效的方式抑制糖精的消耗。然而,在两种最低剂量(18和32 mg / kg)下,GBR 12909和氯米帕明均能使可卡因的厌恶感减弱。在最高剂量(50 mg / kg)下,GBR 12909对可卡因的糖精消耗产生了与可卡因相当的抑制作用,而氯米帕明的条件抑制作用在该剂量下仍然相对较弱。这些结果表明,由NET抑制引起的可卡因的肾上腺素能作用可能比其在DAT和SERT上的作用更重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号